There are 16 resources available
Welcome and Introduction
Presenter: N. Leighl, CA
Session: Welcome and introduction
Resources:
Slides
Webcast
The Structure, Function and Role of KRAS in Normal Cell Homeostasis
Presenter: M. Broggini, IT
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Epidemiology of KRAS Activating Mutations: Incidence and Biology Across Tumours with Emphasis on Lung Cancer
Presenter: L. Mezquita, ES
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Impact of Co-mutations
Presenter: F. Skoulidis, US
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Molecular Tissue Testing of NSCLC for KRAS Mutations: Who, How and When?
Presenter: K. Kerr, UK
Session: Session 1 – KRAS Biology, Epidemiology, Pathology
Resources:
Slides
Webcast
Clinical Development of KRAS G12C Inhibitors – Where Are We Now?
Presenter: P. Janne, US
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Resistance to KRAS G12C Inhibitors – What Do We Know?
Presenter: G. Dy, US
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Moving Forward with KRAS G12C Inhibitors – Combinations, Sequencing, Early stage
Presenter: C. Lindsay, UK
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Clinical Cases and Expert Panel Discussion: Single Agent Case with Liver Toxicity
Presenter: G. Pasello, IT
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Clinical Cases and Expert Panel Discussion: Combination Therapy
Presenter: C. Bestvina, US
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast